These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32250312)

  • 1. Huntington's Disease Clinical Trials Corner: April 2020.
    Rodrigues FB; Wild EJ
    J Huntingtons Dis; 2020; 9(2):185-197. PubMed ID: 32250312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's Disease Clinical Trials Corner: November 2022.
    Estevez-Fraga C; Tabrizi SJ; Wild EJ
    J Huntingtons Dis; 2022; 11(4):351-367. PubMed ID: 36463457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington’s Disease Clinical Trials Corner: February 2018.
    Rodrigues FB; Wild EJ
    J Huntingtons Dis; 2018; 7(1):89-98. PubMed ID: 29480210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrabenazine (Xenazine) for Huntington's chorea.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):7-8. PubMed ID: 19172140
    [No Abstract]   [Full Text] [Related]  

  • 5. Huntington's Disease Clinical Trials Corner: March 2024.
    Estevez-Fraga C; Tabrizi SJ; Wild EJ
    J Huntingtons Dis; 2024; 13(1):1-14. PubMed ID: 38489195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deutetrabenazine for the treatment of Huntington's chorea.
    Bashir H; Jankovic J
    Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's Disease Clinical Trials Corner: April 2022.
    Estevez-Fraga C; Rodrigues FB; Tabrizi SJ; Wild EJ
    J Huntingtons Dis; 2022; 11(2):105-118. PubMed ID: 35570498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's Disease Clinical Trials Corner: January 2019.
    Rodrigues FB; Quinn L; Wild EJ
    J Huntingtons Dis; 2019; 8(1):115-125. PubMed ID: 30776019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's Disease Clinical Trials Corner: June 2019.
    Rodrigues FB; Ferreira JJ; Wild EJ
    J Huntingtons Dis; 2019; 8(3):363-371. PubMed ID: 31381524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's Disease Clinical Trials Corner: August 2018.
    Rodrigues FB; Wild EJ
    J Huntingtons Dis; 2018; 7(3):279-286. PubMed ID: 30103342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrabenazine: for chorea associated with Huntington's disease.
    Scott LJ
    CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deutetrabenazine (Austedo) for Huntington's chorea and tardive dyskinesia.
    Med Lett Drugs Ther; 2018 Apr; 60(1545):65-68. PubMed ID: 29667946
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Trials Corner: September 2017.
    Rodrigues FB; Wild EJ
    J Huntingtons Dis; 2017; 6(3):255-263. PubMed ID: 28968245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's Disease Clinical Trials Corner: August 2023.
    Estevez-Fraga C; Tabrizi SJ; Wild EJ
    J Huntingtons Dis; 2023; 12(2):169-185. PubMed ID: 37483021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VMAT2 Inhibitors for Tardive Dyskinesia-Practice Implications.
    Peckham AM; Nicewonder JA
    J Pharm Pract; 2019 Aug; 32(4):450-457. PubMed ID: 29455579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deutetrabenazine in the treatment of Huntington's disease.
    Richard A; Frank S
    Neurodegener Dis Manag; 2019 Feb; 9(1):31-37. PubMed ID: 30624137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychopharmacology of Huntington disease.
    Petersén Å; Weydt P
    Handb Clin Neurol; 2019; 165():179-189. PubMed ID: 31727211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.